A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

NCT07521241 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Liver Disease (CLD)

Interventions

DRUG: AD-230, AD-2301

Sponsor

Addpharma Inc.